S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
NASDAQ:FEMY

Femasys News Headlines

$6.99
-0.01 (-0.14 %)
(As of 10/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.98
$7.08
50-Day Range
$6.52
$7.96
52-Week Range
$6.50
$13.75
Volume7,641 shs
Average Volume118,510 shs
Market Capitalization$82.48 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Media Mentions By Week

Femasys Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FEMY
News Sentiment

-0.01

0.35

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FEMY Articles
This Week

2

1

FEMY Articles
Average Week

Get Femasys News Delivered to You Automatically

Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter.

Femasys (NASDAQ FEMY) News Headlines Today

SourceHeadline
MarketBeat logoFemasys Inc. (NASDAQ:FEMY) Short Interest Up 293.8% in September
americanbankingnews.com - October 13 at 7:40 AM
MarketBeat logoFemasys Inc. (NASDAQ:FEMY) Short Interest Update
americanbankingnews.com - October 1 at 4:20 AM
finance.yahoo.com logoFemasys Inc. to Present at The MedTech Conference
finance.yahoo.com - September 23 at 6:08 PM
finance.yahoo.com logoFemasys Inc. To Join the Russell Microcap® Index
finance.yahoo.com - September 20 at 5:33 PM
nasdaq.com logoBullish Femasys Inc. (NASDAQ:FEMY) insiders filled their treasuries with US$2.6m worth of stock over last year
nasdaq.com - September 18 at 2:05 PM
finance.yahoo.com logoBullish insiders bet US$2.6m on Femasys Inc. (NASDAQ:FEMY)
finance.yahoo.com - September 18 at 2:05 PM
finance.yahoo.com logoFemasys Inc. Announces the Appointment of Edward Evantash, M.D. as Chief Medical Officer
finance.yahoo.com - September 1 at 6:04 PM
finance.yahoo.com logoFemasys Inc. Announces Financial Results for the Second Quarter of 2021
finance.yahoo.com - August 12 at 8:59 AM
barrons.com logoFemasys Inc.
barrons.com - July 29 at 8:36 PM
finance.yahoo.com logoFemasys Inc. Announces First Patient Treated in Pivotal Trial for FemaSeed
finance.yahoo.com - July 20 at 2:54 PM
benzinga.com logoClinical Trials Underway on Key Female Oriented Healthcare Advances from new IPO Launch: Femasys (NASDAQ: FEMY)
benzinga.com - July 19 at 7:24 PM
reuters.com logoFemasys Inc
reuters.com - July 5 at 7:22 PM
finance.yahoo.com logoFemasys Inc. (FEMY) stock forecast and price target
finance.yahoo.com - July 4 at 6:41 PM
nasdaq.com logoFemasys Inc. Common Stock (FEMY)
nasdaq.com - June 22 at 7:54 AM
finance.yahoo.com logoPeter Thiel’s Atai Life Sciences and 5 Other Companies List Shares
finance.yahoo.com - June 19 at 9:31 AM
marketwatch.com logoFemasys Inc. IPO Priced at Middle of Expectations >FEMY
marketwatch.com - June 18 at 10:11 PM
marketwatch.com logoFemasys Shares Roughly Flat in Trading Debut After IPO >FEMY
marketwatch.com - June 18 at 10:11 PM
Get Femasys News Delivered to You Automatically

Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/18/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.